An extensive review determined that the ingredient, oral phenylephrine, doesn’t actually relieve nasal congestion.

The new voicemail that was added 4-6 weeks back is totally unacceptable and CVS should be embarrassed of themselves. It’s a horrendous disease that came in and negatively infected the system ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

The FDA is proposing the removal of phenylephrine, a popular nasal decongestant, in oral form from over-the-counter use. Here ...

By Danielle Kaye CVS Health abruptly ousted its chief executive, Karen S. Lynch, on Friday as the pharmacy and health care conglomerate struggled with sluggish growth and faced pressure from ...

For allergy sufferers ... flush the pollen out of the eye or the nose,” Matichak said. If over-the-counter medications aren’t alleviating your symptoms, Matichak said it may be time to check in with ...

The changes are in addition to CVS’s plan to cut 2,900 corporate jobs across the nation, including more than 630 in Rhode Island WOONSOCKET, R.I. — CVS Health will exit its core infusion ...

CVS Health (NYSE: CVS, $67.46, Market Capitalization: $84.86 billion), a leading health solutions company in the US, is considering a potential break-up to separate its retail and insurance units.

CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services. It operates through the following segments: Health Care Benefits, Health Services, Pharmacy ...

America’s largest drug store chain named a new chief executive officer on Friday, with longtime CVS Health executive David Joyner replacing Karen Lynch. CVS also withdrew its 2024 profit ...

CVS Health CEO Karen Lynch has stepped down, with company shares sinking 19% this year and the health-care giant struggling on several fronts. Company shares tumbled again Friday after CVS Health ...